Cryopak

Overview

Cryopak is a cold-chain packaging and thermal-assurance vendor for life sciences shipments. Its public product set includes insulated shippers, gel packs, phase-change materials, temperature data loggers, package testing, temperature mapping, thermal qualification, and sustainability programs such as R3 and EcoGel.

For a launch team, Cryopak should be evaluated as a direct packaging, refrigerant, testing, and monitoring partner rather than a rental-first cold-chain-as-a-service platform or active-container network. The useful diligence question is whether Cryopak can provide the exact packout, frozen refrigerant availability, data logger workflow, testing documentation, and capacity reservation needed for the product’s first commercial lanes.

Cold Chain and Packaging Capability Model

The framework below standardizes how Rx Almanac evaluates packaging-contract-manufacturing capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Cryopak is evaluated as a direct packaging, refrigerant, testing, and monitoring partner rather than a rental-first cold-chain-as-a-service platform or active-container network.

Capability	Buyer should compare	Cryopak readout
Temperature range and packaging formats	Ambient, CRT, 2-8C, frozen, ultra-cold, cryogenic, parcel, pallet, active, and passive configurations.	Core packaging system. Cryopak offers passive insulated containers, parcel and pallet shipper formats, gel packs, refrigerants, and phase-change materials for temperature-sensitive shipments.
Qualification, validation, and lane design	ISTA/GDP qualification, thermal modeling, lane profiles, SOPs, stability assumptions, and validation documentation.	Core / validate by lane. Cryopak has testing, temperature mapping, qualification, shipping-lane mapping, and thermal-simulation capabilities; request product-specific qualification packets.
Reusable, rental, and sustainability model	Reusable shipper programs, rental pools, reverse logistics, waste reduction, carbon reporting, and cost per use.	Partial fit. R3, EcoGel, and recycled-material programs support a sustainability story, but buyers should not assume a rental-first closed-loop model without contract detail.
Monitoring, sensors, and excursion response	Temperature indicators, IoT sensors, real-time tracking, excursion triage, and quality documentation.	Documented device / software layer. Cryopak Connect, iMiniUSB, and ConsolePlus support monitoring and data-logger workflows; confirm alerting, data ownership, calibration, and QMS handoff.
Global logistics support and availability	Manufacturing footprint, inventory availability, international compliance, distribution partners, and launch surge reliability.	North America-oriented capacity signal. Recent gel-pack manufacturing and spiral-freezing investments improve the supply and conditioning story; verify exact site, SKU, and launch-volume availability.
Specialty, biologic, and CGT readiness	Suitability for high-value biologics, cell/gene therapies, clinical supply, specialty pharmacy, or direct-to-patient shipments.	Strong category fit with validation. Cryopak is relevant for biologics, specialty medicines, high-volume refrigerated injectables, diagnostics, and health-system shipments when the packout evidence matches the lane.

Buyer Fit

• Best-fit motion: Include Cryopak when the need is a packaged cold-chain system: shipper design, refrigerants / gel packs, qualification support, monitoring devices, and manufacturing / freezing capacity.
• Therapy and product fit: Strongest fit is for specialty medicines, biologics, refrigerated products, diagnostics, and other temperature-sensitive programs where validated passive packaging is central to launch continuity.
• Commercial fit: Pricing is Custom/RFP. Compare total cost across packaging units, gel-pack or refrigerant supply, conditioning, qualification work, monitoring devices, reuse / disposal handling, and reserved launch capacity.
• Profile signal: Cryopak is more relevant to supply-chain, quality, packaging, specialty-pharmacy, and health-system procurement teams than to patient-services or commercial access owners.
• Contracting diligence: Confirm temperature profile, duration, ambient assumptions, data-logger workflow, escalation process, inventory reservation, and whether any reuse or return program is operationally included.

Differentiators

• Packaging plus refrigerant supply: Cryopak combines shippers, gel packs, refrigerants, and PCMs rather than acting as a single-component supplier.
• Monitoring layer: Cryopak Connect, iMiniUSB, and ConsolePlus give the profile more monitoring depth than packaging-only suppliers, though buyers should validate real-time versus logger-based workflows.
• Testing and mapping services: ISTA-certified testing history, temperature mapping, qualification, shipping lane mapping, and thermal simulation make Cryopak relevant when the buyer needs documented validation support.
• North American capacity story: The Garden State gel-pack manufacturing acquisition and Atlanta spiral-freezing investment strengthen Cryopak’s ability to discuss frozen refrigerant availability and lead times.
• Procurement access: The Vizient pharmacy partner relationship can matter for health systems and pharmacy aggregation groups, but current contract scope and participating entities should be confirmed.

RFP Questions

• Which exact temperature profiles, durations, and ambient conditions have been qualified for products like ours?
• Which shipper, gel pack, refrigerant, and data-logger SKUs are included in the proposed packout?
• How can Cryopak provide ISTA reports, thermal maps, route assumptions, conditioning SOPs, and excursion documentation templates?
• What Cryopak Connect, iMiniUSB, or ConsolePlus included, and how will data move into our quality, logistics, or 3PL workflows?
• What frozen refrigerant capacity, lead time, and contingency inventory can be reserved before launch?
• What is any reuse, return, recycling, or EcoGel program operationally included, and how are cost and waste measured?
• What if buying through Vizient or a health-system procurement path, what exact contract scope, SKUs, and implementation references apply?

Recent Activity

• Acquired the gel-pack manufacturing segment of Garden State Cold Storage in 2024, adding Carteret, New Jersey capacity and increasing the reported Cryopak North American plant footprint.
• 2026: Continued investing in Atlanta freezing capabilities, including spiral-freezing capacity tied to refrigerant supply and conditioning.
• 2026: Continued public positioning around insulated shippers, gel packs, monitoring devices, testing, sustainable packaging, and pharmacy / health-system cold-chain procurement.